Tetrabenazine

丁苯那嗪

Report date: 2026/01/15 09:22:55
NMEFirst In Class

Base Information

Drug NameTetrabenazine
Drug Alias NameTetrabenazinum四苯喹嗪特苯那嗪Tetrabenazina四苯纳 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynaptic vesicular amine transporter inhibitors
TargetsSynaptic vesicular amine transporter
Therapy Area/IndicationsTourette SyndromeHuntington Disease
Global Approved IndicationsHuntington Disease
Approved Indications in ChinaHuntington Disease
Original Approved Country/TerritoryUnited States
Original Approved Date2008/08/15
Country/TerritoryUnited StatesIndiaMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesAlfresa PharmaBausch Health Companies IncShandong Bausch & Lamb Freda Pharmaceutical Co Ltd
Inactive CompaniesPrestwick Pharmaceuticals IncBausch Health Americas IncDr.Reddy's Laboratories Ltd
Active IndicationsHuntington Disease
Inactive IndicationsTourette Syndrome

Other Information

ATC CodeN07XX06
Related LinksWikipediaDrugBankKEGG